CELH
Overvalued by 104.6% based on the discounted cash flow analysis.
Market cap | $18.68 Billion |
---|---|
Enterprise Value | $17.93 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.77 |
Beta | 1.3 |
Outstanding Shares | 231,006,000 |
Avg 30 Day Volume | 3,569,992 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 102.65 |
---|---|
PEG | -42.98 |
Price to Sales | 14.19 |
Price to Book Ratio | 70.97 |
Enterprise Value to Revenue | 13.6 |
Enterprise Value to EBIT | 67.3 |
Enterprise Value to Net Income | 98 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...